Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Human cardiac stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression

Alessandra Amendola, Gloria Garoffolo, Paola Songia, Silvia Ferrari, Giacomo Bernava, Paola Canzano, Veronika Myasoedova, Francesca Colavita, Concetta Castilletti, Giuseppe Sberna, Maria Rosaria Capobianchi, Marco Agrifoglio, Gualtiero I. Colombo, Paolo Poggio, View ORCID ProfileMaurizio Pesce
doi: https://doi.org/10.1101/2020.11.06.20226423
Alessandra Amendola
1Istituto Nazionale Malattie Infettive, Lazzaro Spallanzani; IRCCS, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gloria Garoffolo
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
3PhD Program in Translational and Molecular Medicine - DIMET; Università di Milano - Bicocca, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Songia
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Silvia Ferrari
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
4PhD Program in Translational Medicine; Università degli studi di Pavia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giacomo Bernava
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Canzano
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Veronika Myasoedova
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesca Colavita
1Istituto Nazionale Malattie Infettive, Lazzaro Spallanzani; IRCCS, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Concetta Castilletti
1Istituto Nazionale Malattie Infettive, Lazzaro Spallanzani; IRCCS, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giuseppe Sberna
1Istituto Nazionale Malattie Infettive, Lazzaro Spallanzani; IRCCS, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Rosaria Capobianchi
1Istituto Nazionale Malattie Infettive, Lazzaro Spallanzani; IRCCS, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Agrifoglio
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
5Università degli studi di Milano; Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gualtiero I. Colombo
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paolo Poggio
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurizio Pesce
2Centro Cardiologico Monzino; IRCCS, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Maurizio Pesce
  • For correspondence: maurizio.pesce@ccfm.it
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Patients with severe respiratory syndrome caused by SARS-CoV-2 undergo cardiac complications due to hyper-inflammatory conditions. Although the presence of the virus has been detected in the myocardium of infected patients, and infection of cardiac cells may involve ACE2 receptor, the underlying molecular/cellular mechanisms are still uncharacterized. We analyzed expression of ACE2 receptor in primary human cardiac stromal cells using proteomic and transcriptomic methods before exposing them to SARS-CoV-2 in vitro. Using conventional and high sensitivity PCR methods, we measured virus production in the cellular supernatants and monitored the intracellular viral bioprocessing. We performed high-resolution imaging to show the sites of intracellular viral production. We finally used Q-RT-PCR assays to detect genes linked to innate immunity and fibrotic pathways coherently regulated in cells exposed to virus. Our findings indicate that human cardiac stromal cells have a susceptibility to SARS-CoV-2 infection and produce variable viral yields depending on the extent of cellular ACE2 receptor expression. Interestingly, these cells also evolved toward hyper-inflammatory/pro-fibrotic phenotypes independently of ACE2 levels, suggesting a dual cardiac damage mechanism that could account for the elevated numbers of cardiac complications in severe COVID-19 cases.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

N/A

Funding Statement

This work has been financed by a Grant from Regione Lombardia (POR FESR 2014-2020-LINEA 2A COVID-grant no. 1850333) granted to M.P. and A.A. M.P. and A.A. are supported by Institutional grants (Ricerca Corrente, 5 per 1000) issued by Italian Ministry of Health. A.A. was supported also by COVID-2020-12371817 and COVID-2020-12371675 program grants from Italian Ministry of Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Derivation of cells from human atrial appendage was approved by the Ethical Committee at Centro Cardiologico Monzino, IRCCS, Milano. A written agreement was obtained by each patient before collection of the material, during routine cardiac surgery interventions.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will made available at a public data repository upon request after publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted November 10, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Human cardiac stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Human cardiac stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression
Alessandra Amendola, Gloria Garoffolo, Paola Songia, Silvia Ferrari, Giacomo Bernava, Paola Canzano, Veronika Myasoedova, Francesca Colavita, Concetta Castilletti, Giuseppe Sberna, Maria Rosaria Capobianchi, Marco Agrifoglio, Gualtiero I. Colombo, Paolo Poggio, Maurizio Pesce
medRxiv 2020.11.06.20226423; doi: https://doi.org/10.1101/2020.11.06.20226423
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Human cardiac stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression
Alessandra Amendola, Gloria Garoffolo, Paola Songia, Silvia Ferrari, Giacomo Bernava, Paola Canzano, Veronika Myasoedova, Francesca Colavita, Concetta Castilletti, Giuseppe Sberna, Maria Rosaria Capobianchi, Marco Agrifoglio, Gualtiero I. Colombo, Paolo Poggio, Maurizio Pesce
medRxiv 2020.11.06.20226423; doi: https://doi.org/10.1101/2020.11.06.20226423

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cardiovascular Medicine
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)